US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist
  • 1.030
  • -0.030-2.83%
Close Apr 25 16:00 ET
  • 1.010
  • -0.020-1.94%
Post 16:06 ET
44.51MMarket Cap-1226P/E (TTM)

About Quince Therapeutics Company

Quince Therapeutics, Inc.(formerly Cortexyme, Inc.） is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Company Profile

SymbolQNCX
Company NameQuince Therapeutics
Listing DateMay 9, 2019
Founded2012
CEOMr. Dirk Thye
MarketNASDAQ
Employees32
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 273
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-910-5717
Websitehttp://quincetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dirk Thye
  • Chief Executive Officer, Chief Medical Officer and Director
  • 1.33M
  • Brendan Hannah
  • Chief Operating Officer, Chief Compliance Officer, Chief Business Officer, Principal Financial Officer and Principal Accounting Officer
  • 847.50K
  • David A. Lamond
  • Chairman of the Board
  • 106.06K
  • Dr. Charles S. Ryan, J.D.,PhD
  • President
  • 817.56K
  • Dr. Luca Benatti, PhD
  • Director
  • 52.80K
  • Rajiv Patni, M.D.
  • Director
  • --
  • Christopher J. Senner
  • Independent Director
  • 87.56K
  • June Bray
  • Independent Director
  • 80.06K
  • Dr. Margaret McLoughlin, PhD
  • Independent Director
  • 82.06K
  • Dr. Una S. Ryan,PhD
  • Lead Independent Director
  • 98.56K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg